Sichuan Kelun Pharmaceutical Co Ltd (002422) — Financial Flexibility Index
Sichuan Kelun Pharmaceutical Co Ltd (002422) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥930.89 Million (operating CF CN¥537.31 Million minus capex CN¥393.58 Million) represents 0% of total liabilities (CN¥11.48 Billion). Check 002422 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sichuan Kelun Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Sichuan Kelun Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Sichuan Kelun Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Sichuan Kelun Pharmaceutical Co Ltd. Explore 002422 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥4.26 Billion | CN¥2.64 Billion | CN¥10.54 Billion | ▼ -30.7% |
| 2024 | 0.58x | CN¥6.17 Billion | CN¥4.49 Billion | CN¥10.58 Billion | ▲ +10.3% |
| 2023 | 0.53x | CN¥7.11 Billion | CN¥5.34 Billion | CN¥13.44 Billion | ▲ +127.8% |
| 2022 | 0.23x | CN¥4.02 Billion | CN¥3.13 Billion | CN¥17.33 Billion | ▲ +5.3% |
| 2021 | 0.22x | CN¥3.84 Billion | CN¥2.85 Billion | CN¥17.41 Billion | ▲ +15.0% |
| 2020 | 0.19x | CN¥3.45 Billion | CN¥2.22 Billion | CN¥18.01 Billion | ▼ -5.1% |
| 2019 | 0.20x | CN¥3.55 Billion | CN¥2.22 Billion | CN¥17.58 Billion | ▼ -22.7% |
| 2018 | 0.26x | CN¥4.28 Billion | CN¥2.95 Billion | CN¥16.40 Billion | ▲ +56.0% |
| 2017 | 0.17x | CN¥2.68 Billion | CN¥1.20 Billion | CN¥16.01 Billion | ▼ -35.4% |
| 2016 | 0.26x | CN¥3.09 Billion | CN¥1.73 Billion | CN¥11.94 Billion | ▼ -3.9% |
| 2015 | 0.27x | CN¥3.08 Billion | CN¥1.24 Billion | CN¥11.42 Billion | ▼ -30.6% |
| 2014 | 0.39x | CN¥3.98 Billion | CN¥1.22 Billion | CN¥10.23 Billion | ▼ -7.0% |
| 2013 | 0.42x | CN¥3.31 Billion | CN¥1.05 Billion | CN¥7.92 Billion | ▼ -22.9% |
| 2012 | 0.54x | CN¥3.18 Billion | CN¥402.77 Million | CN¥5.87 Billion | ▼ -41.6% |
| 2011 | 0.93x | CN¥2.35 Billion | CN¥342.93 Million | CN¥2.53 Billion | ▲ +105.9% |
| 2010 | 0.45x | CN¥796.51 Million | CN¥149.29 Million | CN¥1.77 Billion | ▲ +50.0% |
| 2009 | 0.30x | CN¥525.98 Million | CN¥250.69 Million | CN¥1.75 Billion | ▼ -1.8% |
| 2008 | 0.31x | CN¥447.66 Million | CN¥221.08 Million | CN¥1.47 Billion | ▼ -2.6% |
| 2007 | 0.31x | CN¥343.47 Million | CN¥168.42 Million | CN¥1.10 Billion | — |